Shares of Moderna and Metagenomi, backed by Bayer, fell 32%
Shares of Metagenomi Technologies, a genetic drug company backed by Bayer Healthcare, opens a new tab and Moderna, opens a new tab, fell 32% during its debut on the Nasdaq. The stock opened for trading at $10.25, compared to its IPO price of $15 per share.
POPULAR POSTS
Trump opts for personal ties to choose his government team
November 15, 2024
UK sets new climate target for 2035
November 13, 2024
Children go back to school after Valencia floods
November 13, 2024
Researchers document huge decline in African elephants
November 13, 2024
LIVE STREAM
